OptimizeRx Corp (NAS:OPRX)
$ 10.54 -0.27 (-2.5%) Market Cap: 191.66 Mil Enterprise Value: 219.54 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 77/100

OPTIMIZERx Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 04:20PM GMT
Release Date Price: $82.57 (-3.76%)
Jailendra P. Singh;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. Good morning, everyone. I'm Jailendra Singh, health care technology and distribution analyst at Crédit Suisse. Thanks, everyone, for joining us for this session. Next up, we have OptimizeRx. From the company, we have Will Febbo, CEO and Director; Ed Stelmakh, CFO; and Andy D'Silva, SVP of Finance.

OptimizeRx is a health technology company enabling care-focused engagement between life sciences automization, health care providers and patients at critical junctures throughout the patient journey. I have some prepared questions, so we are doing this in a fireside chat format. I'll plan to cover that. But if anyone from the audience has a question, please e-mail them to me at [email protected].

Will, Ed, Andy, thank you so much for doing this. Really appreciate it.

William J. Febbo;Edward Stelmakh
OptimizeRx Corporation - CEO & Director;OptimizeRx Corporation - CFO

Nice to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot